At what enterprise value was ANTELLIQ acquired in 2013?

During the acquisition of ANTELLIQ by BC PARTNERS in 2013, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of ANTELLIQ when it was acquired by BC PARTNERS?

The exact EV/EBITDA multiple for ANTELLIQ is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was ANTELLIQ acquired by BC PARTNERS?

ANTELLIQ was acquired by BC PARTNERS in 2013.

What was the revenue of ANTELLIQ at the time of the deal?

The revenue of ANTELLIQ at the time of the deal is estimated to be in the range of 150M - 250M EUR. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the ANTELLIQ acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ANTELLIQ deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.bcpartners.com/portfolio/antelliq/

← DATABASE

Home Database Healthcare & PharmaANTELLIQ

06/2013

ANTELLIQ acquired by BC PARTNERS

FRANCE Life Sciences / Animal Health EV 1b - 4b EUR

Context

BC Partners has successfully finalized the acquisition of a majority stake in the share capital of the target from a UK-based investment trust. This strategic transaction represents a secondary leveraged buyout designed to accelerate the organization’s shift toward electronic identification and digital monitoring technologies. The strategic rationale for the move centers on the acquirer's objective to capitalize on the increasing global adoption of mandatory livestock traceability and the rising demand for sophisticated animal intelligence solutions.

ANTELLIQ, which reported an EBITDA margin of in 2012, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Antelliq is a specialized technology organization dedicated to the development and deployment of digital identification, traceability, and monitoring solutions for animals. The entity’s business model focuses on providing high-precision hardware and data analytics to facilitate the management of livestock and companion animals. Its value proposition is anchored in enhancing animal welfare and productivity through real-time health and behavioral insights. Strategically, the firm operates at the intersection of veterinary science and digital reality, utilizing proprietary sensors and tracking software to provide actionable data for farmers and veterinarians. By maintaining a leadership position in the global animal intelligence market, the organization ensures a mission-critical role in the agricultural supply chain and pet care ecosystems. The entity emphasizes industrialized reliability to address the increasing demand for food safety and personalized animal care.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2012

2011

Other operations with ANTELLIQ

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
12/2018	MERCK & CO.	ANTELLIQ	FRANCE	Animal Health
03/2016	PSP INVESTMENTS	ANTELLIQ	FRANCE	Animal Health

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 150M - 250M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ANTELLIQ by BC PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: bc partners